Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH MEDIA
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC

Brown Fat Research Advances with a Ground-Breaking MRI Scan

By BiotechDaily International staff writers
Posted on 05 May 2014
Image: The first MRI scan to show “brown fat” in a living adult could prove to be an essential step towards a new wave of therapies to aid the fight against diabetes and obesity (Photo courtesy of Warwick Medical School).
Image: The first MRI scan to show “brown fat” in a living adult could prove to be an essential step towards a new wave of therapies to aid the fight against diabetes and obesity (Photo courtesy of Warwick Medical School).
A magnetic resonance imaging (MRI) scan is the first to show “brown fat” in a living adult, and could provide vital information for new treatments to aid the fight against diabetes and obesity.

Researchers from Warwick University Medical School (Coventry, UK) and University Hospitals Coventry (UK) and Warwickshire NHS [National Health Service] Trust used MRI-based technology to identify and validate the presence of brown adipose tissue in a living adult.

Brown fat has become a heated subject for scientists because its ability to use energy and burn calories, helping to keep weight in check. Understanding the brown fat tissue and how it can be utilized is of growing interest in the search to help obese individuals or at a high risk of developing diabetes.

Dr. Thomas Barber, from the department of metabolic and vascular health at Warwick Medical School, explained, “This is an exciting area of study that requires further research and discovery. The potential is there for us to develop safe and effective ways of activating this brown fat to promote weight loss and increase energy expenditure--but we need more data to be able to get to that point. This particular proof of concept is key, as it allows us to pursue MRI techniques in future assessments and gather this required information.”

The study published January 2014 in the Journal of Clinical Endocrinology and Metabolism described the advantages of using MRI scans over the existing method of positron emission tomography (PET). While PET imaging reveals brown fat activity, it is subject to a range of limitations including the challenge of signal variability from a changing environmental temperature.

In contrast to the PET data, which only displays activity, MRI can show brown fat content whether active or not, providing a detailed insight into where it can be found in the adult body. These data could become vital in the development of future therapies that seek to activate deposits of brown fat.

Dr. Barber added, “The MRI allows us to distinguish between the brown fat, and the more well-known white fat that people associate with weight gain, due to the different water to fat ratio of the two tissue types. We can use the scans to highlight what we term ‘regions of interest’ that can help us to build a picture of where the brown fat is located.”

With the proof of concept study now completed, the next phase of research is to further corroborate this technique across a larger group of adults.

Related Links:

Warwick University Medical School
University Hospitals Coventry



Channels

Genomics/Proteomics

view channel
Image: Pluristem technicians produce PLacental eXpanded (PLX) cells in the company\'s state-of-the-art facility (Photo courtesy of Pluristem Therapeutics).

Placental Cells Secrete Factors That Protect Nerves from Ischemic Damage

Cells derived from placenta have been found to protect PC12 cells—rat-derived cells that behave similarly to and are used as stand-ins to study human nerve cells—in a culture-based ischemic stroke model.... Read more

Drug Discovery

view channel
Image: Researchers have attached two drugs—TRAIL and Dox—onto graphene strips. TRAIL is most effective when delivered to the external membrane of a cancer cell, while Dox is most effective when delivered to the nucleus, so the researchers designed the system to deliver the drugs sequentially, with each drug hitting a cancer cell where it will do the most damage (Photo courtesy of Dr. Zhen Gu, North Carolina State University).

Anticancer Drug Delivery System Utilizes Graphene Strip Transporters

The ongoing search by cancer researchers for targeted drug delivery systems has generated a novel approach that uses graphene strips to transport simultaneously the anticancer agents TRAIL (tumor necrosis... Read more

Biochemistry

view channel

Blocking Enzyme Switch Turns Off Tumor Growth in T-Cell Acute Lymphoblastic Leukemia

Researchers recently reported that blocking the action of an enzyme “switch” needed to activate tumor growth is emerging as a practical strategy for treating T-cell acute lymphoblastic leukemia. An estimated 25% of the 500 US adolescents and young adults diagnosed yearly with this aggressive disease fail to respond to... Read more

Therapeutics

view channel
Image: Cancer cells infected with tumor-targeted oncolytic virus (red). Green indicates alpha-tubulin, a cell skeleton protein. Blue is DNA in the cancer cell nuclei (Photo courtesy of Dr. Rathi Gangeswaran, Bart’s Cancer Institute).

Innovative “Viro-Immunotherapy” Designed to Kill Breast Cancer Cells

A leading scientist has devised a new treatment that employs viruses to kill breast cancer cells. The research could lead to a promising “viro-immunotherapy” for patients with triple-negative breast cancer,... Read more

Lab Technologies

view channel
Image: MIT researchers have designed a microfluidic device that allows them to precisely trap pairs of cells (one red, one green) and observe how they interact over time (Photo courtesy of Burak Dura, MIT).

New Device Designed to See Communication between Immune Cells

The immune system is a complicated network of many different cells working together to defend against invaders. Effectively combating an infection depends on the interactions between these cells.... Read more

Business

view channel

Program Designed to Provide High-Performance Computing Cluster Systems for Bioinformatics Research

Dedicated Computing (Waukesha, WI, USA), a global technology company, reported that it will be participating in the Intel Cluster Ready program to deliver integrated high-performance computing cluster solutions to the life sciences market. Powered by Intel Xeon processors, Dedicated Computing is providing a range of... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.